Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administration - PubMed (original) (raw)
Neuropeptide FF attenuates allodynia in models of chronic inflammation and neuropathy following intrathecal or intracerebroventricular administration
N Altier et al. Eur J Pharmacol. 2000.
Abstract
Experiments were conducted to explore the effects of Neuropeptide FF acting at spinal and supraspinal sites in models of chronic inflammatory or neuropathic pain and of acute pain. Neuropeptide FF was administered intrathecally (i.t.; 10.0, 25.0 and 50.0 nmol) or intracerebroventricularly (i.c.v.; 10.0, 12.5 and 15.0 nmol) either 24 h after inflammation-inducing injections of Freund's Complete Adjuvant in one hind paw or 7 days after unilateral sciatic nerve constriction. Evoked pain was assessed by measuring the withdrawal response threshold (in grams of pressure) to a mechanical stimulus applied to the plantar surface of the injured paw. Neuropeptide FF dose-dependently attenuated the allodynic response (i.e., withdrawal from a normally innocuous stimulus) to mechanical stimulation in the inflammatory and neuropathic model following i.t. (ED50=20.86 nmol and ED50=18.91 nmol, respectively) and i.c.v. (ED50=12.31 nmol and ED50=11.68 nmol, respectively) administration. Pretreatment with naloxone (2.0 mg/kg; s.c.) attenuated the anti-allodynic effect of i.t. or i.c.v. Neuropeptide FF in rats experiencing inflammatory, but not neuropathic pain. In contrast, Neuropeptide FF administered i.t. (10.0, 25.0 and 50.0 nmol) or i.c.v. (10.0, 12.5 and 15.0 nmol) had no effect on the response to acute thermal or mechanical stimulation. Neuropeptide FF injected i.t. or i.c.v. in inflamed or neuropathic rats did not produce any sign of motor dysfunction. These results suggest that Neuropeptide FF acting at spinal and supraspinal sites plays a role in modulating chronic, but not acute pain. Furthermore, the results suggest that the anti-allodynic effect of Neuropeptide FF is mediated indirectly by naloxone-sensitive opioid mechanisms in rats subjected to inflammatory, but not neuropathic pain.
Similar articles
- Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models.
Xu M, Kontinen VK, Panula P, Kalso E. Xu M, et al. Peptides. 1999;20(9):1071-7. doi: 10.1016/s0196-9781(99)00100-x. Peptides. 1999. PMID: 10499424 - Enhanced 3,5-dihydroxyphenylglycine-induced sustained nociceptive behaviors in rats with neuropathy or chronic inflammation.
Scotland PE, Coderre TJ. Scotland PE, et al. Behav Brain Res. 2007 Dec 3;184(2):150-6. doi: 10.1016/j.bbr.2007.07.003. Epub 2007 Jul 10. Behav Brain Res. 2007. PMID: 17681386 - Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
McGaraughty S, Wismer CT, Zhu CZ, Mikusa J, Honore P, Chu KL, Lee CH, Faltynek CR, Jarvis MF. McGaraughty S, et al. Br J Pharmacol. 2003 Dec;140(8):1381-8. doi: 10.1038/sj.bjp.0705574. Epub 2003 Nov 17. Br J Pharmacol. 2003. PMID: 14623769 Free PMC article. - The emergence of animal models of chronic pain and logistical and methodological issues concerning their use.
Coderre TJ, Laferrière A. Coderre TJ, et al. J Neural Transm (Vienna). 2020 Apr;127(4):393-406. doi: 10.1007/s00702-019-02103-y. Epub 2019 Nov 18. J Neural Transm (Vienna). 2020. PMID: 31741117 Review.
Cited by
- Involvement of Mammalian RF-Amide Peptides and Their Receptors in the Modulation of Nociception in Rodents.
Ayachi S, Simonin F. Ayachi S, et al. Front Endocrinol (Lausanne). 2014 Oct 2;5:158. doi: 10.3389/fendo.2014.00158. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25324831 Free PMC article. Review. - BN-9, a chimeric peptide with mixed opioid and neuropeptide FF receptor agonistic properties, produces nontolerance-forming antinociception in mice.
Li N, Han ZL, Wang ZL, Xing YH, Sun YL, Li XH, Song JJ, Zhang T, Zhang R, Zhang MN, Xu B, Fang Q, Wang R. Li N, et al. Br J Pharmacol. 2016 Jun;173(11):1864-80. doi: 10.1111/bph.13489. Epub 2016 Apr 21. Br J Pharmacol. 2016. PMID: 27018797 Free PMC article. - Neuropeptide FF-related gene in fish (Larimichthys polyactis): identification, characterization, and potential anti-inflammatory function.
Xiao R, Guo Z, Zheng LB, Huang W, Chi CF, Lou B. Xiao R, et al. Mol Biol Rep. 2022 Jul;49(7):6385-6394. doi: 10.1007/s11033-022-07447-5. Epub 2022 May 3. Mol Biol Rep. 2022. PMID: 35503491 - Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development.
Nguyen T, Marusich J, Li JX, Zhang Y. Nguyen T, et al. J Med Chem. 2020 Nov 12;63(21):12387-12402. doi: 10.1021/acs.jmedchem.0c00643. Epub 2020 Jul 31. J Med Chem. 2020. PMID: 32673481 Free PMC article. - Functional modulation of human delta opioid receptor by neuropeptide FF.
Ankö ML, Panula P. Ankö ML, et al. BMC Neurosci. 2005 Apr 4;6:21. doi: 10.1186/1471-2202-6-21. BMC Neurosci. 2005. PMID: 15804369 Free PMC article.